6949.TW Pell Bio-Med Technology Co., Ltd.

Healthcare Biotechnology Taiwan Stock Exchange
37.55 TWD
Close of Nov 6, 2026
34.75 1,490
Market cap
TWD 49.2B
P/E
-
P/B
19.14x
ROE
-12.9%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 6949.TW undervalued?

Graham number

The Graham number of Pell Bio-Med Technology Co., Ltd. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Pell Bio-Med Technology Co., Ltd. fundamental analysis

No fundamental analysis for Pell Bio-Med Technology Co., Ltd. yet.

Pell Bio-Med Technology Co., Ltd. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Pell Bio-Med Technology Co., Ltd.

Pell Bio-Med Technology Co., Ltd., a biomedical company, engages in the research, development, manufacturing, and sales of chimeric antigen recombinant T cell (CAR-T), and other related services and products. It offers autologous adipose-derived stem cell (ADSC) products to treat osteoarthritis and cartilage defects in the knee; cytokine-induced Killer cells to treat various tumors; and dendritic cell-activated cytokine-induced killer to treat solid tumors. The company is al…

Full company profile